Complementary DNA Sequencing: Expressed Sequence Tags and Human Genome Project

  • Mark D. Adams
    Section of Receptor Biochemistry and Molecular Biology, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892.
  • Jenny M. Kelley
    Section of Receptor Biochemistry and Molecular Biology, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892.
  • Jeannine D. Gocayne
    Section of Receptor Biochemistry and Molecular Biology, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892.
  • Mark Dubnick
    Section of Receptor Biochemistry and Molecular Biology, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892.
  • Mihael H. Polymeropoulos
    Laboratory of Biochemical Genetics, National Institute of Mental Health, Neuroscience Center at St. Elizabeth's Hospital, Washington, DC 20032.
  • Hong Xiao
    Laboratory of Biochemical Genetics, National Institute of Mental Health, Neuroscience Center at St. Elizabeth's Hospital, Washington, DC 20032.
  • Carl R. Merril
    Laboratory of Biochemical Genetics, National Institute of Mental Health, Neuroscience Center at St. Elizabeth's Hospital, Washington, DC 20032.
  • Andrew Wu
    Section of Receptor Biochemistry and Molecular Biology, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892.
  • Bjorn Olde
    Section of Receptor Biochemistry and Molecular Biology, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892.
  • Ruben F. Moreno
    Section of Receptor Biochemistry and Molecular Biology, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892.
  • Anthony R. Kerlavage
    Section of Receptor Biochemistry and Molecular Biology, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892.
  • W. Richard McCombie
    Section of Receptor Biochemistry and Molecular Biology, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892.
  • J. Craig Venter
    Section of Receptor Biochemistry and Molecular Biology, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892.

抄録

<jats:p> Automated partial DNA sequencing was conducted on more than 600 randomly selected human brain complementary DNA (cDNA) clones to generate expressed sequence tags (ESTs). ESTs have applications in the discovery of new human genes, mapping of the human genome, and identification of coding regions in genomic sequences. Of the sequences generated, 337 represent new genes, including 48 with significant similarity to genes from other organisms, such as a yeast RNA polymerase II subunit; <jats:italic>Drosophila</jats:italic> kinesin, <jats:italic>Notch</jats:italic> , and <jats:italic>Enhancer of split</jats:italic> ; and a murine tyrosine kinase receptor. Forty-six ESTs were mapped to chromosomes after amplification by the polymerase chain reaction. This fast approach to cDNA characterization will facilitate the tagging of most human genes in a few years at a fraction of the cost of complete genomic sequencing, provide new genetic markers, and serve as a resource in diverse biological research fields. </jats:p>

収録刊行物

  • Science

    Science 252 (5013), 1651-1656, 1991-06-21

    American Association for the Advancement of Science (AAAS)

被引用文献 (21)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ